NebuPent (Fresenius Kabi USA, LLC)


Welcome to the PulseAid listing for the NebuPent drug offered from Fresenius Kabi USA, LLC. This Antiprotozoal [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Fresenius Kabi USA, LLC
NON-PROPRIETARY NAME: PENTAMIDINE ISETHIONATE
SUBSTANCE NAME: PENTAMIDINE ISETHIONATE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Antiprotozoal [EPC]
ROUTE: RESPIRATORY (INHALATION)
DOSAGE FORM: INHALANT
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2011-02-15
END MARKETING DATE: 0000-00-00


NebuPent HUMAN PRESCRIPTION DRUG Details:

Item DescriptionNebuPent from Fresenius Kabi USA, LLC
LABELER NAME: Fresenius Kabi USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 300(mg/6mL)
START MARKETING DATE: 2011-02-15
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-877_9d14a7f6-afab-40d6-b3d2-4ebe8bed0605
PRODUCT NDC: 63323-877
APPLICATION NUMBER: NDA019887

Other PENTAMIDINE ISETHIONATE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
APP Pharmaceuticals, LLCPentam 300
Fresenius Kabi USA, LLCNebuPent
Seton PharmaceuticalsPentamidine Isethionate